Caveat Emptor: The Perils of Panel Testing in Hereditary Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Caveat Emptor: The Perils of Panel Testing in Hereditary Breast Cancer

Published:2019-08-20 Issue:24 Volume:37 Page:2176-2177
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Taylor Amy¹,Tischkowitz Marc¹

Affiliation:

1. Amy Taylor, PhD, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom; and Marc Tischkowitz, MD, PhD, Cambridge University Hospitals National Health Service Trust and University of Cambridge, Cambridge, United Kingdom

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.19.00122

Reference9 articles.

1. Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?

2. Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

3. Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care

4. Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of genomics in global cancer prevention;Nature Reviews Clinical Oncology;2020-09-24

2. Reply to M.S. Copur et al, A. Taylor et al, and P.S. Rajagopal et al;Journal of Clinical Oncology;2019-08-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP